Fiscal fourth‑quarter revenue rose 6% to $63.67 billion as Cardinal Health reported a profit of $398 million, or $1.70 a share, up from $239 million and $1 a share a year earlier. The healthcare company’s two main business lines delivered mixed sales, yet the company expects revenue to grow in both segments in the coming fiscal year.

When stripping out certain one‑time items, adjusted per‑share earnings were $2.91, ahead of the $2.42 anticipated by analysts, according to Fact Set. Cardinal Health highlighted a boost to profit of $100 million from tariff refunds, translating to 31 cents a share.

The company’s outlook remains positive, with management projecting continued revenue expansion across its distribution and medical‑supply segments. The Q4 results underscore Cardinal Health’s focus on cost controls and strategic pricing to sustain earnings growth.

Overall, Cardinal Health’s mixed sales dynamics are offset by robust profitability metrics and a favorable tax‑related refund, positioning the firm for a stronger performance in the next fiscal year.